14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Mar 04, 2024 Sell 9 297 Adawi Kamal Common Stock
Mar 04, 2024 Sell 3 487 Adawi Kamal Common Stock
Feb 29, 2024 Buy 9 804 Aballi John Common Stock
Feb 20, 2024 Buy 75 000 Adawi Kamal Common Stock
Feb 20, 2024 Buy 175 000 Aballi John Common Stock
Feb 06, 2024 Sell 6 738 Adawi Kamal Common Stock
Oct 17, 2023 Sell 33 819 Aballi John Common Stock
Aug 31, 2023 Buy 9 803 Aballi John Common Stock
Jul 24, 2023 Buy 15 000 Kim Paul Stock Option(right to buy)
Jul 24, 2023 Buy 0 Kim Paul
Jun 15, 2023 Buy 167 Tullis James L L Common Stock
Jun 15, 2023 Buy 13 500 Nova Tina Susan Stock Option(right to buy)
Jun 09, 2023 Buy 9 000 Stokes Frank Stock Option(right to buy)
Jun 09, 2023 Buy 9 000 Birk Brian Stock Option(right to buy)
Jun 09, 2023 Buy 9 000 Pallares Ebetuel Stock Option(right to buy)
Jun 09, 2023 Buy 9 000 Hooker Ana Stock Option(right to buy)
Jun 09, 2023 Buy 9 000 Johnson Wendy S. Stock Option(right to buy)
Mar 02, 2023 Sell 3 667 Adawi Kamal Common Stock
Mar 02, 2023 Sell 3 667 Hazeltine Mark Common Stock
Feb 27, 2023 Buy 100 000 Adawi Kamal Common Stock
Feb 27, 2023 Buy 100 000 Hazeltine Mark Common Stock
Feb 08, 2023 Sell 5 821 Hazeltine Mark Common Stock
Feb 08, 2023 Sell 5 821 Adawi Kamal Common Stock
Dec 08, 2022 Buy 90 000 Aballi John Common Stock
Oct 16, 2022 Buy 350 000 Aballi John Restricted Stock Units
Oct 16, 2022 Buy 0 Aballi John
Oct 16, 2022 Buy 0 Aballi John
Jun 16, 2022 Buy 9 000 Johnson Wendy S. Stock Option(right to buy)
Jun 16, 2022 Buy 9 000 Johnson Wendy S. Stock Option(right to buy)
Jun 16, 2022 Buy 9 000 Pallares Ebetuel Stock Option(right to buy)
Jun 16, 2022 Buy 9 000 Nova Tina Susan Stock Option(right to buy)
Jun 16, 2022 Buy 9 000 Nova Tina Susan Stock Option(right to buy)
Jun 16, 2022 Buy 9 000 Tullis James L L Stock Option(right to buy)
Jun 16, 2022 Buy 9 000 Tullis James L L Stock Option(right to buy)
Jun 16, 2022 Buy 9 000 Hooker Ana Stock Option(right to buy)
Jun 16, 2022 Buy 9 000 Birk Brian Stock Option(right to buy)
Jun 16, 2022 Buy 9 000 Birk Brian Stock Option(right to buy)
Jun 16, 2022 Buy 9 000 Stokes Frank Stock Option(right to buy)
Jun 16, 2022 Buy 9 000 Stokes Frank Stock Option(right to buy)
Mar 01, 2022 Sell 3 241 Zack Debra Common Stock
Mar 01, 2022 Sell 3 241 Hazeltine Mark Common Stock
Mar 01, 2022 Sell 3 241 Adawi Kamal Common Stock
Mar 01, 2022 Sell 4 322 Rocca Fortunato R. Common Stock
Feb 04, 2022 Buy 50 000 Zack Debra Common Stock
Feb 04, 2022 Buy 63 500 Hazeltine Mark Common Stock
Feb 04, 2022 Buy 63 500 Adawi Kamal Common Stock
Feb 04, 2022 Buy 75 000 Rocca Fortunato R. Common Stock
Sep 03, 2021 Buy 1 000 Johnson Wendy S. Common Stock
Aug 05, 2021 Sell 6 800 Tullis James L L Common Stock
Aug 04, 2021 Sell 2 100 Tullis James L L Common Stock
Aug 03, 2021 Sell 4 300 Tullis James L L Common Stock
Aug 02, 2021 Sell 1 800 Tullis James L L Common Stock
Jul 29, 2021 Buy 15 000 Hooker Ana Stock Option(right to buy)
Jul 29, 2021 Buy 0 Hooker Ana
Jun 29, 2021 Sell 5 379 Tullis James L L Common Stock
Jun 28, 2021 Sell 10 858 Tullis James L L Common Stock
Jun 25, 2021 Sell 8 763 Tullis James L L Common Stock
Jun 17, 2021 Buy 9 000 Pallares Ebetuel Stock Option(right to buy)
Jun 17, 2021 Buy 15 000 Stokes Frank Stock Option(right to buy)
Jun 17, 2021 Buy 9 000 Robertson Bruce C Stock Option(right to buy)
Jun 17, 2021 Buy 9 000 Nova Tina Susan Stock Option(right to buy)
Jun 17, 2021 Buy 9 000 Johnson Wendy S. Stock Option(right to buy)
Jun 17, 2021 Buy 9 000 Birk Brian Stock Option(right to buy)
Jun 17, 2021 Buy 9 000 Tullis James L L Stock Option(right to buy)
Jun 17, 2021 Buy 0 Stokes Frank
May 17, 2021 Buy 1 934 Hazeltine Mark Common Stock
May 17, 2021 Sell 1 934 Hazeltine Mark Stock Option(right to buy)
Mar 13, 2021 Buy 0 Hazeltine Mark Common Stock
Mar 13, 2021 Buy 680 Hazeltine Mark Stock Option(right to buy)
Mar 13, 2021 Buy 2 995 Hazeltine Mark Stock Option(right to buy)
Mar 13, 2021 Buy 92 574 Hazeltine Mark Stock Option(right to buy)
Mar 13, 2021 Buy 27 500 Hazeltine Mark Stock Option(right to buy)
Mar 13, 2021 Buy 12 500 Hazeltine Mark Stock Option(right to buy)
Feb 23, 2021 Buy 37 500 Adawi Kamal Common Stock
Feb 23, 2021 Buy 12 500 Adawi Kamal Stock Option(right to buy)
Feb 23, 2021 Buy 37 500 Zack Debra Common Stock
Feb 23, 2021 Buy 12 500 Zack Debra Stock Option(right to buy)
Feb 23, 2021 Buy 50 000 Rocca Fortunato R. Common Stock
Feb 23, 2021 Buy 40 000 Rocca Fortunato R. Stock Option(right to buy)
Feb 05, 2021 Sell 3 000 Tullis James L L Common Stock
Jan 25, 2021 Sell 28 021 Hunt Holdings Limited Partnership Common Stock
Jan 22, 2021 Sell 23 646 Hunt Holdings Limited Partnership Common Stock
Jan 21, 2021 Sell 50 000 Hunt Holdings Limited Partnership Common Stock
Jan 20, 2021 Sell 30 000 Hunt Holdings Limited Partnership Common Stock
Jan 19, 2021 Sell 30 000 Hunt Holdings Limited Partnership Common Stock
Jan 19, 2021 Sell 257 Tullis James L L Common Stock
Jan 15, 2021 Sell 1 014 Tullis James L L Common Stock
Jan 13, 2021 Sell 1 729 Tullis James L L Common Stock
Jan 13, 2021 Sell 4 000 Tullis James L L Common Stock
Jan 12, 2021 Sell 15 000 Hunt Holdings Limited Partnership Common Stock
Jan 11, 2021 Sell 7 394 Hunt Holdings Limited Partnership Common Stock
Jan 08, 2021 Sell 15 186 Hunt Holdings Limited Partnership Common Stock
Jan 07, 2021 Sell 10 000 Hunt Holdings Limited Partnership Common Stock
Dec 15, 2020 Sell 125 000 Nmsic Co-investment Fund, L.p. Common Stock
Dec 15, 2020 Sell 12 000 Tullis James L L Common Stock
Dec 11, 2020 Sell 7 500 Tullis James L L Common Stock
Dec 10, 2020 Sell 10 000 Tullis James L L Common Stock
Nov 11, 2020 Sell 150 Hunt Holdings Limited Partnership Common Stock
Nov 10, 2020 Sell 9 045 Hunt Holdings Limited Partnership Common Stock
Nov 09, 2020 Sell 6 752 Hunt Holdings Limited Partnership Common Stock
INSIDER POWER
74.659
Last 100 transactions
Buy: 1 756 457 | Sell: 517 990 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 74.659.

In total, the insiders bought 1 756 457 and sold 517 990 XGN shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Exagen Inc.

Exagen. Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its lead testing product is AVISE CTD that enables diff... XGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT